Investor Relations News / Events Press Releases Email Alerts Press Releases All News 2019 2018 2017 2016 2015 2014 iBio Fibrosis Therapeutics Program Receives NIH Grant Support Sep 9, 2015 iBio to Receive US Patent for Influenza Therapeutic Aug 11, 2015 Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland Jun 8, 2015 Vaccine Improvement Patent Awarded to iBio May 4, 2015 iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics Apr 27, 2015 iBio European Plague Vaccine Patent Emerges From Opposition Period Mar 30, 2015 iBio Adds Anthrax Antibodies to Product Pipeline Feb 25, 2015 iBio Receives US and European Patents for Protein Expression Technology Feb 12, 2015 iBio Adds to iBioModulator Portfolio and Product Pipeline Feb 4, 2015 iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting Dec 10, 2014 1 2 3 4 5 6
Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland Jun 8, 2015
iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics Apr 27, 2015
iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting Dec 10, 2014
